Argitalpenak (44) María Antonia Fortuño Cebamanos argitalpenak

2024

  1. Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19

    Blood Cancer Journal, Vol. 14, Núm. 1

2021

  1. Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies

    Blood Cancer Journal, Vol. 11, Núm. 12

2017

  1. Multicentric study of the effect of pre-analytical variables in the quality of plasma samples stored in biobanks using different complementary proteomic methods

    Journal of Proteomics, Vol. 150, pp. 109-120

2014

  1. Downregulation of G protein-coupled receptor kinase 2 levels enhances cardiac insulin sensitivity and switches on cardioprotective gene expression patterns

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1842, Núm. 12, pp. 2448-2456

2011

  1. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 301, Núm. 6, pp. 2372-2382

2010

  1. Aldosterone and the cardiovascular system: A dangerous association

    Hormone Molecular Biology and Clinical Investigation, Vol. 4, Núm. 2, pp. 539-548

  2. Vascular effects of cardiotrophin-1: A role in hypertension?

    Journal of Hypertension, Vol. 28, Núm. 6, pp. 1261-1272

2008

  1. Aldosterone induces cardiotrophin-1 expression in HL-1 adult cardiomyocytes

    Endocrinology, Vol. 149, Núm. 10, pp. 4970-4978

  2. Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 294, Núm. 1

2007

  1. Loss of myocardial LIF receptor in experimental heart failure reduces cardiotrophin-1 cytoprotection. A role for neurohumoral agonists?

    Cardiovascular Research, Vol. 75, Núm. 3, pp. 536-545

  2. Stimulation of cardiac apoptosis in essential hypertension. Potential role of Angiotensin II (Hypertension (2002) 39, (75-80))

    Hypertension

2006

  1. Differential hypertrophic effects of cardiotrophin-1 on adult cardiomyocytes from normotensive and spontaneously hypertensive rats

    Journal of Molecular and Cellular Cardiology, Vol. 41, Núm. 5, pp. 902-913

2005

  1. Characterization of the protective effects of cardiotrophin-1 against non-ischemic death stimuli in adult cardiomyocytes

    Cytokine, Vol. 30, Núm. 5, pp. 282-292

  2. Is plasma cardiotrophin-1 a marker of hypertensive heart disease?

    Journal of Hypertension, Vol. 23, Núm. 3, pp. 625-632

2003

  1. Cardiomyocyte apoptosis in hypertensive cardiomyopathy

    Cardiovascular Research, Vol. 59, Núm. 3, pp. 549-562

  2. Clinical implications of apoptosis in hypertensive heart disease

    American Journal of Physiology - Heart and Circulatory Physiology

  3. Involvement of cardiomyocyte survival–apoptosis balance in hypertensive cardiac remodeling

    Expert Review of Cardiovascular Therapy, Vol. 1, Núm. 2, pp. 293-307

2002

  1. Stimulation of cardiac apoptosis in essential hypertension potential role of angiotensin II

    Hypertension, Vol. 39, Núm. 1, pp. 75-80

2001

  1. Cardiomyocyte apoptotic cell death in arterial hypertension: Mechanisms and potential management

    Hypertension

  2. Effects of antihypertensive agents on the left ventricle:Clinical implications

    American Journal of Cardiovascular Drugs, Vol. 1, Núm. 4, pp. 263-279